Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Economy & Forex

News : Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

Global Glycobiology Market to Rise at 14.64% between 2020 and 2027

10/15/2020 | 04:50am EST

GLOBAL GLYCOBIOLOGY MARKET SIZE STUDY, BY PRODUCT (ENZYMES, OTHER ENZYMES, INSTRUMENTS KITS, CARBOHYDRATES, REAGENTS & CHEMICALS), BY APPLICATION (DRUG DISCOVERY & DEVELOPMENT, DISEASE DIAGNOSTICS, OTHER APPLICATIONS), BY END-USER ( ACADEMIC RESEARCH INSTITUTES, PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, CLINICAL LABORATORIES) AND REGIONAL FORECASTS 2020-2027

According to a new report by Report Ocean, the global glycobiology market will be rising at a healthy CAGR of 14.64% between 2020 and 2027, registering a remarkable rise. The report, titled "Global Glycobiology Market Size study, by Product (Enzymes, Other Enzymes, Instruments, Kits, Carbohydrates, Reagents & Chemicals), by Application (Drug Discovery & Development, Disease Diagnostics, Other Applications), by End-user (Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories) and Regional Forecasts 2020-2027," further states that the market stood at US$1.4 bn in 2019.

GET SAMPLE COPY @ https://www.reportocean.com/industry-verticals/sample-request?report_id=bw1485

The main driving force behind the growth of the global glycobiology market is the increase in the funding for glycomics and proteomics studies. The rising investments for R&D for technological advancements in the glycomics instrumentation are also supporting the growth of this market significantly. Over the coming years, the expansion of pharmaceutical and the biotechnology industries are expected to create lucrative opportunity for this market. However, presence of stringent regulatory frameworks and the high degree of consolidation in the market may hinder the market from rising properly in the near future.

Presence of Large Pool of Players to Maintain Competition in Global Market

The presence of a large pool of participants points towards a highly fragmented and competitive business landscape in the global glyocobiology market. Merck KGaA, Agilent Technologies, Thermo Fisher Scientific, New England Biolabs, Shimadzu Corporation, Takara Bio, S-BIO, Waters Corporation, Asparia Glycomics S.L., and Bio-Techne are some of the leading suppliers of glycobiology products across the world. These market participants have been relying on high investment in R&D to remain relevant in the competition. They are also concentrating on new product launches to maintain their market value. For instance, in June 2019, Agilent Technologies rolled out Infinity Lab LC/MSD iQ Systems, while sometime earlier, Thermo Fisher Scientific (US) had launched UHMR Hybrid Quadrupole-Orbitrap Mass Spectrometer.

Key companies are also focusing on strategic partnerships to cut competition. Shimadzu Corp. entered into a partnership agreement with PREMIER Biosoft to launch LCMS-9030 Q-TOF mass spectrometry system for advance lipidomics and glycomics data processing.

North America to Continue to Dominate over Coming Years

On the basis of the region, Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa have emerged as the key segments of the worldwide glycobiology market. Among these, North America has been leading the global market. Researchers project the scenario to remain more or less the same over the forthcoming years, thanks to the presence of key pharmaceutical and biopharmaceutical companies in the region. Asia Pacific is also expected to report significant growth on the back of emerging pharmaceutical and biopharmaceutical industries and heightened investments by CROs in this region over the next few years, states the research report.

Impact of COVID 19 on Global Glycobiology Market

The global economic slowdown due to the COVID pandemic is also reflected on the worldwide glycobiology market. The investments in R&D have decreased, which is hampering the growth of this market. However, the momentum in this market is likely to return as the economy begins to recover.

Key Findings: *The drug discovery and development application segment is expected to register a high growth in the coming years. *North America emerged as the dominant regional market and is anticipated to retain its position in the near future. *The high number of players is expected to maintain the competition.

The Global Glycobiology Market is segmented into:

By Product *Enzymes *Other Enzymes *Instruments *Kits *Carbohydrates *Reagents & Chemicals

By Application * Drug Discovery & Development * Disease Diagnostics * Other Applications

By End User * Academic Research Institutes * Pharmaceutical and Biotechnology Companies * Clinical Laboratories

By Region *North America *Europe *Asia Pacific *Latin America *Rest of the World

Companies Mentioned in the Report *Merck KGaA *Agilent Technologies *Thermo Fisher Scientific *New England Biolabs *Shimadzu Corporation *Takara Bio *S-BIO *Waters Corporation *Asparia Glycomics S.L. *Bio-Techne

READ FULL REPORT @ https://www.reportocean.com/industry-verticals/sample-request?report_id=bw1485

Media Contact

Company Name: Report Ocean

Contact Person: Nishi Sharma

Email: nishi@reportocean.com

Phone: +91-9997112116

Address:Classic Tower, Rajnagar Extension

City: Ghaziabad

State: UP, 201017

Country: India

Website: www.reportocean.com

Source: www.abnewswire.com

.

(C) 2020 M2 COMMUNICATIONS, source M2 PressWIRE

Stocks mentioned in the article
ChangeLast1st jan.
AGILENT TECHNOLOGIES, INC. -0.55% 113.87 Delayed Quote.34.30%
BIO-TECHNE CORPORATION 0.28% 299.18 Delayed Quote.35.91%
MERCK KGAA 1.63% 137.4 Delayed Quote.28.33%
SHIMADZU CORPORATION -0.26% 3830 End-of-day quote.11.34%
TAKARA BIO INC. 1.38% 3020 End-of-day quote.46.82%
THERMO FISHER SCIENTIFIC -0.49% 476.15 Delayed Quote.45.01%
WATERS CORPORATION -1.28% 231.51 Delayed Quote.0.23%
Latest news "Economy & Forex"
12:09pPortugal aims to vaccinate nearly 10% of population during 1st phase
RE
12:08pHapless holidays? U.S. data suggest hit to 'Main Street' hiring
RE
12:07pU.S. Senate confirms Waller to Fed's Board of Governors
RE
12:03pCovid-19 Drags on Europe's Economies as U.S., Asia Recovery Continues -- Update
DJ
12:02pTrump says he will support a coronavirus relief bill
RE
12:01pU.S. to hold Arctic refuge oil lease sale in early January, before Biden takes office
RE
11:58aU.S. weekly jobless claims fall; services sector activity slows
RE
11:57aWORLD BANK : Provides $97 Million to Strengthen COVID-19 Response and Reforms in the Education Sector in Cameroon
PU
11:55aKroger raises 2020 profit view despite slowing online sales growth
RE
11:54aHackers targeting groups involved in COVID-19 vaccine distribution, IBM warns
RE
Latest news "Economy & Forex"